Safety and Efficacy of Enhanced Recovery After Surgery in Neurocritical Care

Recruiting N/A Interventional Study
Neurocritical Care Traumatic Brain Injury Cerebrovascular Disease Moderate or Severe Coma
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 75
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
80 (estimated)
Sponsor
Shanghai 6th People's Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Enhanced recovery after surgery (ERAS) is a strategy of perioperative management aimed to accelerate the rehabilitation of patients through various optimized perioperative managements as well as ongoing adherence to a patient-focused, multidisciplinary, and multimodal approach. Alleviating the injury and stress caused by surgery or disease is the core principle of ERAS, which has been shown to red…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age 18-75 years old * Patients with moderate or severe acute traumatic brain injury or cerebrovascular disease requiring neurosurgical intensive care treatment * Hospitalization time ≥ 1 week * The guardian is able to understand and actively cooperate in completing the project…
Contacts

Hao Chen, M.D., Ph.D.

8602164369181

hao.chen@shsmu.edu.cn

CONTACT